Tumour proliferation and apoptosis in human uterine cervix carcinoma II: Correlations with clinical outcome

Radiotherapy and Oncology

Volumn 50, Issue 1, 1999, Pages 93-101

  Tsang, Richard W ^a   Wong, C Shun ^a,b   Fyles, Anthony W ^a   Levin, W ^a   Manchul, L A ^a   Milosevic, M ^a   Chapman, William ^a   Li, Yu qing ^b   Pintilie, Melania ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Apoptosis; Bromodeoxyuridine; Carcinoma of the cervix; Labelling index; Proliferation

Indexed keywords

BROXURIDINE;

ARTICLE; CANCER GRADING; CANCER GROWTH; DIAGNOSTIC VALUE; FEMALE; HUMAN; ISOTOPE LABELING; MAJOR CLINICAL STUDY; MITOSIS INDEX; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA;

ANALYSIS OF VARIANCE; ANTIMETABOLITES; APOPTOSIS; BROMODEOXYURIDINE; CARCINOMA; CELL DIVISION; DISEASE-FREE SURVIVAL; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MITOSIS; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REMISSION INDUCTION; S PHASE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 0033019266     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00119-4     Document Type: Article

References (31)

1. Bennett MH, Wilson GD, Dische S, et al. Tumour proliferation assessed by combined histological and flow cytometric analysis: Implications for therapy in squamous cell carcinoma in the head and neck. Br. J. Cancer 1992;65:870-878.
2. Bolger BS, Symonds RP, Stanton PD, et al. Prediction of radiotherapy response of cervical carcinoma through measurement of proliferation rate. Br. J. Cancer 1996;74:1223-1226.
3. Cole DJ, Brown DC, Crossley E, Alcock CJ, Gatter KC. Carcinoma of the cervix uteri: An assessment of the relationship of tumour proliferation to prognosis. Br. J. Cancer 1992;65:783-785.
4. Cox DR. Regression models and lifetables. J. R. Stat. Soc. 1972;34:187-202.
5. Dubray B, Breton C, Delic J, et al. In vitro radiation-induced apoptosis and early response to low dose radiotherapy in non-Hodgkin's lymphomas. Radiother. Oncol. 1998;46:185-191.
6. Evan GI, Brown L, Whyte M, Harrington E. Apoptosis and the cell cycle. Curr. Opin. Cell Biol. 1995;7:825-834.
7. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother. Oncol. 1992;25:27-39.
8. Fyles AW, Milosevic M, Wong R, et al. Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother. Oncol. 1998;48:149-156.
9. Girinsky T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int. J. Radiat. Oncol. Biol. Phys. 1993;27:105-156.
10. Graeber TG, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 1996;379:88-91.
11. Hockel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 1996;56:4509-4515.
12. Isacson C, Kessis TO, Hedrick L, Cho KR. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Res. 1996;56:669-674.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958;53:457-481.
14. Kraxner H, Tamas L, Jaray B, Ribari O, Szentirmay Z, Szende B. Search for prognostic factors in head and neck cancer. Acta Otolaryngol. (Stockh.) 1997;527(Suppl.):145-149.
15. Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int. J. Radiat. Oncol. Biol. Phys. 1993;25:391-397.
16. Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy in cervical carcinoma. Radiother. Oncol. 1995;37:1-9.
17. Meyn RE, Stephens LC, Milas L. Programmed cell death and radioresistance. Cancer Metastas. Rev. 1996;15:119-131.
18. Oka K, Hoshi T, Arai T. Prognostic significance of the PC 10 index as a prospective assay for cervical cancer treated with radiation therapy alone. Cancer 1992;70:1545-1550.
19. Oka K, Nakano T, Hoshi T. Transient increases of growth fraction during fractionated radiation therapy for cervical carcinoma. Cancer 1993;72:2621-2627.
20. Olive PL, Banath JP. Growth fraction measured using the comet assay. Cell Prolif. 1992;25:447-457.
21. Olive PL, Durand RE. Apoptosis: An indicator of radiosensitivity in vitro. Int. J. Radiat. Biol. 1997;71:695-707.
22. Perez CA. Uterine cervix. In: Perez CA, Brady LW, editors. Principles and Practice of Radiation Oncology, 3rd Ed. Phildelphia, PA: Lippincott-Raven, 1997.
23. Perez CA, Grigsby PW, CastroVita H, Lockett MA. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 1995;32:1275-1288.
24. Sheets EE, Yeh J. The role of apoptosis in gynaecologic malignancies. Ann. Med. 1997;29:121-126.
25. Steel GG. Growth Kinetics of Tumours. Oxford: Clarendon Press, 1977.
26. Tsang RW, Fyles AW, Kirkbride P, et al. Proliferation measurements with flow cytometry Tpot in cancer of the uterine cervix: Preliminary results. Int. J. Radiat. Oncol. Biol. Phys. 1995;32:1319-1329.
27. Tsang, R.W., Fyles, A.W., Li, Y.Q., et al. Tumour proliferation and apoptosis in human uterine cervix carcinoma I: Correlations between variables, Radiother. Oncol., 1999;50:93-101.
28. West CM, Davidson SE, Roberts SA, Hunter RD. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br. J. Cancer 1997;76:1184-1190.
29. Wheeler JA, Stephens LC, Tornos C, et al. ASTRO research fellowship: Apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 1995;32:1487-1493.
30. Wilson GD, Dische S, Saunders MI. Studies with bromodeoxyuridine in head and neck cancer and accelerated radiotherapy. Radiother. Oncol. 1995;36:189-197.
31. Wilson GD, Saunders MI, Dische S, et al. Direct comparison of bromodeoxyuridine and Ki-67 labelling indices in human tumours. Cell Prolif. 1996;29:141-152.